MyeloMATCH Master Protocol

Master Screening and Reassessment Protocol (MSRP) for the NCI MyeloMATCH Clinical Trials

More Information

Trial Status
Accepting patients
Trial Phase
Phase 2
Enrollment
2,000 patients (estimated)
Sponsors
National Cancer Institute (NCI)
Tags
Genetic Sequencing
Trial Type
Treatment
Last Update
1 month ago
SparkCures ID
1988
NCT Identifier
NCT05564390

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print this trial to share with your doctor.

We can help answer any questions and connect you (or your patient) with the study team.

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.